Histidine

Histidine

SCHEMBL3985692

Cl.Cl.NC(Cc1c[nH]cn1)C(=O)O

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Histidine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 known ✓ P23219 1/20 0.42
SLC7A5 Q01650 3/20 0.46
CYP3A4 P08684 2/20 0.46
CYP1A2 P05177 1/20 0.45
PKM P14618 3/20 0.42
ALPI P09923 1/20 0.42
XIAP P98170 1/20 0.42
GRIA2 P42262 4/20 0.40
GRIA1 P42261 3/20 0.40
GRIA3 P42263 3/20 0.40
GRIA4 P48058 3/20 0.40
HSD17B10 Q99714 2/20 0.39
KDM4E B2RXH2 2/20 0.39
MEN1 O00255 2/20 0.39
LMNA P02545 2/20 0.39
MAPT P10636 2/20 0.39
BLM P54132 2/20 0.39
PMP22 Q01453 2/20 0.39
KMT2A Q03164 2/20 0.39
HIF1A Q16665 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Histidine SCHEMBL27153440 1.00 SLC7A5 (0.46) SLC7A5CYP3A4CYP1A2PKMALPI
Histidine SCHEMBL94550 1.00 SLC7A5 (0.46) SLC7A5CYP3A4CYP1A2PKMALPI
Histidine SCHEMBL209483 1.00 SLC7A5 (0.46) SLC7A5CYP3A4CYP1A2PKMALPI
Histidine SCHEMBL30286660 1.00 SLC7A5 (0.46) SLC7A5CYP3A4CYP1A2PKMALPI
Histidine SCHEMBL16893958 1.00 SLC7A5 (0.46) SLC7A5CYP3A4CYP1A2PKMALPI
D-Histidine SCHEMBL8002457 1.00 SLC7A5 (0.46) SLC7A5CYP3A4CYP1A2PKMALPI
Histidine SCHEMBL139654 1.00 SLC7A5 (0.46) SLC7A5CYP3A4CYP1A2PKMALPI
Histidine SCHEMBL670490 1.00 SLC7A5 (0.46) SLC7A5CYP3A4CYP1A2PKMALPI
Histidine SCHEMBL3985696 1.00 SLC7A5 (0.46) SLC7A5CYP3A4CYP1A2PKMALPI
Histidine SCHEMBL16893957 1.00 SLC7A5 (0.46) SLC7A5CYP3A4CYP1A2PKMALPI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 93 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3997056-A1 NEW METHOD FOR PREPARING AN INSECT REPELLENT AGENT Centre national de la recherche scientifique (FR) 2022-05-18 EP claimed
WO-2021005214-A1 NEW METHOD FOR PREPARING AN INSECT REPELLENT AGENT CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2021-01-14 WO claimed
CN-106178988-B A kind of polyvinylidene fluoride blending film of photosynthesis-carbon dioxide response and preparation method thereof 台州学院 2019-09-24 CN claimed
CN-100394555-C Method of second step polishing in copper CMP with a polishing fluid containing no oxidizing agent CMP ROHM AND HAAS ELECTRONIC M (US) 2008-06-11 CN claimed
EP-1526163-B1 Method of second step polishing in copper CMP with a polishing fluid containing no oxidizing agent ROHM & HAAS ELECT MAT (US) 2007-08-08 EP claimed
US-20050090106-A1 Method of second step polishing in copper CMP with a polishing fluid containing no oxidizing agent ROHM AND HAAS ELECTRONIC MATERIALS CMP HOLDINGS, INC. 2005-04-28 US claimed
EP-1526163-A1 Method of second step polishing in copper CMP with a polishing fluid containing no oxidizing agent Rohm and Haas Electronic Materials CMP Holdings, Inc. (US) 2005-04-27 EP claimed
CN-1610072-A Method of second step polishing in copper CMP with a polishing fluid containing no oxidizing agent CMP ROHM AND HAAS ELECTRONIC M (US) 2005-04-27 CN claimed
US-20030065239-A1 Non-hazardous basic neutralization of aldehydes ETHICON, INC. 2003-04-03 US claimed
CN-115873067-A RAS inhibitors 锐新医药公司 2023-03-31 CN disclosed
EP-3118211-B1 AMIDE COMPOUNDS, METHODS FOR PREPARATION, AND USE THEREOF AS AGENTS FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY RNA-AND/OR DNA-CONTAINING VIRUSES AND CONCOMITANT DISEASES OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU PHARMENTERPRISES (RU) 2022-10-12 EP disclosed
EP-3997056-A1 NEW METHOD FOR PREPARING AN INSECT REPELLENT AGENT Centre national de la recherche scientifique (FR) 2022-05-18 EP disclosed
CN-109288837-B Amide compounds and their use as agents for the treatment and prophylaxis of diseases caused by RNA-containing and/or DNA-containing viruses and associated diseases 制药有限责任公司 2021-04-30 CN disclosed
WO-2021005214-A1 NEW METHOD FOR PREPARING AN INSECT REPELLENT AGENT CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2021-01-14 WO disclosed
CN-1136808-A Imidazole group-containing pseudodipeptide products and uses thereof EXSYMOL SA (MC) 1996-11-27 CN disclosed
WO-1996031515-A1 SELECTED SOLUBLE ESTERS OF HYDROXYL-CONTAINING INDOLOCARBAZOLES CEPHALON, INC. (US) 1996-10-10 WO disclosed
EP-0420658-B1 A catalyst for asymmetric induction SUMITOMO CHEMICAL CO (JP) 1995-08-30 EP disclosed
EP-0420658-A2 A catalyst for asymmetric induction SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1991-04-03 EP disclosed
EP-0350163-A2 Renin inhibitory peptides BEECHAM GROUP PLC (GB) 1990-01-10 EP disclosed
US-3963691-A POLYPEPTIDES, PEPTIZATION MERCK & CO., INC. (US) 1976-06-15 US disclosed